Latest News
-
First large-scale trial of stem cell therapy for knee osteoarthritis launched
Posted on:
Kolling researcher Professor David Hunter will lead one of the world’s largest clinical trials into the effectiveness of stem cell therapy for those with knee osteoarthritis. More than 400 participants will be recruited for the SCUlpTOR study which will see trial sites established at Royal North Shore Hospital and the Menzies Institute in Hobart. Professor
Research Group/s & Area/s:
-
First Australian imaging technology to deliver research windfall
Posted on:
An exciting project between the University of Sydney and the Northern Sydney Local Health District will see a $15 million, revolutionary scanner installed at Royal North Shore Hospital, greatly improving patient care and research capabilities. Australia’s first Total Body Positron Emission Tomography (TB-PET) scanner will produce faster and higher quality whole-body PET/CT scans, with less
Research Group/s & Area/s:
-
A simple mix of treatments holds the key to better hand function
Posted on:
The base of our thumb may just be a small part of our hand, but osteoarthritis in that area can have a significant impact, making the simplest tasks difficult. The condition especially affects post-menopausal women, with figures indicating up to a third of women over 70 have this type of osteoarthritis. Increasing numbers of people
Research Group/s & Area/s:
-
Researchers drive global call to action to tackle world’s leading cause of death
Posted on:
A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died
Research Group/s & Area/s:
-
Research identifies long-term health impacts of minor crashes
Posted on:
Treatment of whiplash injuries may be modified following research which has found even minor motor vehicle accidents can cause a long-term spinal cord injury. Researchers from the Kolling Institute along with scientists from Northwestern, Stanford and the University of Oklahoma conducted the longitudinal study involving participants who had been involved in a relatively simple rear-end
Research Group/s & Area/s:
-
Research highlights the dangers of early births
Posted on:
Doctors and researchers are increasingly concerned at the steady rise in premature twin births in New South Wales. Professor Jonathan Morris and his team from the Kolling’s Women and Babies Research group analysed over 14,000 twin pregnancies from 2003-2014, finding 49 per cent of twins were born premature before 37 weeks, and 69 per cent
Research Group/s & Area/s:
-
Our researchers secure highly competitive national funding
Posted on:
Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC) More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease.
Research Group/s & Area/s:
-
High tech project offers hope for Parkinson’s treatment
Posted on:
Kolling researchers are set to lead a ground-breaking project to identify new drug therapies for those with Parkinson’s disease. The project has been made possible following Federal Government funding through the National Drug Discovery Centre. Senior Kolling researcher Dr Daniel Whiten has welcomed the announcement, saying the funding will help our team translate our scientific
Research Group/s & Area/s:
-
-
The Kolling unveils new research strategy
Posted on:
The Kolling Institute Research Strategy has been launched, setting the strategic framework for the institute over the next five years and broadening opportunities to achieve high-quality translational research. Three research priority areas have been identified during the formation of the strategy including musculoskeletal, neuroscience and pain, and cardiovascular and renal research. Kolling Institute Executive Director
Research Group/s & Area/s:
